21hon MSN
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and outside experts, with some saying the poorly defined ...
A motorcycle rider initially won a $14 million jury verdict after being hit a “walking-speed” collision, but the court later ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback